Drug Pricing & Pharmacy
Expert articles and analysis related to drug pricing & pharmacy.
AI Summary — Last 24 Hours
Retail and PBM-led GLP-1 management is accelerating: Amazon One Medical expanded a weight-management program that combines primary care, virtual care, and pharmacy services, while Omada joined Optum Rx’s GLP-1 management program—moves that shift obesity treatment toward longitudinal population-health management rather than standalone prescribing (Amazon One Medical GLP-1 program). For ACOs, employers, and Medicare Advantage plans, the immediate tension is whether these models can generate measurable outcomes and drug-spend offsets fast enough to justify high GLP-1 costs, especially as FDA action to limit compounded obesity-drug ingredients could reduce lower-cost supply alternatives and increase pressure on formulary management and value-based contracting (FDA compounding list development).
Related Articles
Are drug prices value-based?
One of the central tensions in pharmaceutical policy is the gap between what a drug is worth and what it actually costs. In theory, a drug’s price should reflect its value — its ability to improve hea...
Omada signs on with Optum Rx's GLP-1 management program
Omada signs on with Optum Rx's GLP-1 management program  Fierce Healthcare
Attorney General Jackson Reaches $11 Million EpiPen Settlement; Medicaid and State Health Plan to Receive Millions in Refunds - Office of Inspector General (.gov)
Attorney General Jackson Reaches $11 Million EpiPen Settlement; Medicaid and State Health Plan to Receive Millions in Refunds  Office of Inspector General (.gov)
Why Cell and Gene Therapy's Biggest Barrier Isn't Scientific
STAT+: Her daughter Mila got a bespoke medicine. Now she’s starting a new biotech to make more
Efforts to make customized medicines at scale have hit commercial and regulatory roadblocks. Julia Vintarello is trying again.
Amazon One Medical's GLP-1 weight program
Amazon One Medical has expanded its healthcare footprint with a weight management program integrating primary care, pharmacy services and virtual care, aiming to address obesity as a chronic condition...
Axsome Drug’s FDA Approval Unlocks New Opportunity in Alzheimer’s Agitation
Axsome Drug’s FDA Approval Unlocks New Opportunity in Alzheimer’s Agitation  MedCity News
New Codes Describe TOFIDENCE for COVID-19 Hospital Treatment
FDA Approves Dextromethorphan-Bupropion for Agitation Due to Alzheimer Disease
STAT+: OxyContin maker Purdue Pharma set to dissolve after judge approves its criminal sentence
At the hearing, the judge heard from mothers who lost sons to overdose, a teenager born into withdrawal, and people who spent years dealing with addiction treatment.